Pfizer Suspends Sales of Bextra April 7, 2005. Pfizer Inc. on Thursday agreed to suspend sales and marketing of the arthritis drug Bextra at the request of U.S. drug regulators, who said the risks, including Stevens Johnson Syndrome (SJS), outweigh the benefits of the drug. (

What is Bextra?

What is the problem?

Who is responsible?

What is being done?

What can you do?

Do I have a case?


Do you have a Bextra SJS case?


See if you have a case. Fill out our simple form to see if you have a Bextra Case.


Read more about Deadlines you need to know.


Get in touch with a lawyer.

Bextra causes Stevens-Johnson syndrome and toxic epidermal necrolysis -- two forms of the same life-threatening skin disease that cause rash, skin peeling, and sores on the mucous membranes. < read more >     

Bextra pulled from the market 4/7/2005
Stevens Johnson Syndrome & Bextra
Stevens Johnson Rash: Bextra recall
Bextra News Web Log - Updated Daily




 Email this page to a friend.


Home  |  Disclaimer  |  Do I Have A Bextra case?

2002-2015 All Rights Reserved Monheit Law.  Site by